Verstegen, N. J. M., Hagen, R. R., Kreher, C., Kuijper, L. H., van den Dijssel, J., Ashhurst, T., Kummer, L. Y. L., Cabeza, V. P., Steenhuis, M., Duurland, M. C., de Jongh, R., van der Schoot, C. E., Konijn, V. A. L., Mul, E., Kedzierska, K., van Dam, K. P. J., Stalman, E. W., Boekel, L., Wolbink, G., ... T2B! immunity against SARS-CoV-2 study group (2024).
T cell activation markers CD38 and HLA-DR indicative of non-seroconversion in anti-CD20-treated patients with multiple sclerosis following SARS-CoV-2 mRNA vaccination.
Journal of Neurology Neurosurgery and Psychiatry, Article jnnp-2023-332224. Advance online publication.
https://doi.org/10.1136/jnnp-2023-332224